Financials

  • Market Capitalization 36.51 M
  • Employee 7
  • Founded 2019
  • CEO N/A
  • Website www.nasuspharma.com
  • Headquarter Israel
  • FIGI N/A
  • Industry N/A
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-12.71
売上高対価格比率
0.06

Related tickers

#名前価格24時間%7日%1か月%1年%時価総額過去7日
4381
BRIA
BrilliA Inc Class A Ordinary Shares
1.48 USD-1.33%+5.71%+20.33%-33.63%37.00 M USD
4384
ENGS
Energys Group Limited - Ordinary Shares
2.59 USD0.00%-9.12%+7.02%+174.07%36.91 M USD
4393
PFAI
Pinnacle Food Group Limited - Class A Common Shares
3.05 USD+12.13%+17.31%-1.93%+32.03%35.80 M USD
4403
DGNX
Diginex Limited - Ordinary Shares
1.20 USD-3.23%-6.25%-30.23%-92.00%34.96 M USD